Breaking News

Financial Report: Neuland Laboratories Ltd.

Revenues increased 14.5%, posted profit in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Neuland Laboratories FY 1Q12 1Q Revenues: $23.2 million (+15%) 1Q Earnings: $0.2 million (loss of $1.1 million 1Q FY11) Comments: Growth in the quarter was driven by the company’s products and services from its API, contract research, manufacturing, and peptides synthesis businesses....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters